Weekly robustness evaluation of intensity-modulated proton therapy for oesophageal cancer.

CONCLUSION: IMPT reduces the dose to OARs significantly, while achieving adequate target coverage in the majority of patients. Re-planning was necessary for both IMPT and VMAT due to anatomical changes.
PMID: 32663538 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - July 10, 2020 Category: Radiology Authors: Anakotta RM, van der Laan HP, Visser S, Ribeiro CO, Dieters M, Langendijk JA, Both S, Korevaar EW, Sijtsema NM, Knopf A, Muijs CT Tags: Radiother Oncol Source Type: research